Cargando…
Decreased expression of serum semaphorin 3B is associated with poor prognosis of patients with hepatocellular carcinoma
Semaphorin 3B (SEMA-3B), which belongs to the semaphorin family, has an important role in cell apoptosis and inhibition of angiogenesis. A previous study by our group revealed that SEMA-3B was downregulated in tumor tissues of patients with hepatocellular carcinoma (HCC) and exerts anti-motility and...
Autores principales: | Li, Guang-Zhen, Shen, Di, Li, Guang-Hong, Wei, Meng, Zheng, Li-Jie, Liu, Zeng-Li, Sun, Rong-Qi, Zhou, Shao-Jun, Zhang, Zong-Li, Gao, Yan-Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851624/ https://www.ncbi.nlm.nih.gov/pubmed/33603844 http://dx.doi.org/10.3892/etm.2021.9667 |
Ejemplares similares
-
Decreased expression of protocadherin 20 is associated with poor prognosis in hepatocellular carcinoma
por: Wu, Yanqin, et al.
Publicado: (2016) -
Overexpression of semaphorin 3A promotes tumor progression and predicts poor prognosis in hepatocellular carcinoma after curative resection
por: Hu, Zhi-Qiang, et al.
Publicado: (2016) -
Serum semaphorin4C as an auxiliary diagnostic biomarker for breast cancer
por: Wang, Ya, et al.
Publicado: (2021) -
Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018) -
Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma
por: He, Fei, et al.
Publicado: (2015)